Number of patients | Median age (range) (years) | Sex | Median duration of symptoms (range) (months) | Site of fissure | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Anterior | Posterior | ||||||||||
Placebo | 22 | 36 (22–54) | 12F, 10M | 8 (4–24) | 5 | 17 | |||||
0.2% GTN | 23 | 35 (22–81) | 12F, 11M | 8 (4–36) | 6 | 17 | |||||
Variable dose GTN | 23 | 36 (21–72) | 9F, 14M | 7 (3–24) | 3 | 20 |